Navigation Links


Day in Medical Technology

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

... All patients received a dose of 234 mg on day 1 in the deltoid muscle. From day 8 and monthly thereafter, patients were assigned ... muscle one week apart (Day 1 at 234 mg and day 8 at 156 mg), followed by injections every month ...

Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing

... events than patients given edoxaban twice a day (BID). The analysis finds that bleeding ... curve or AUC). Delivering a compound twice per day generally allows for more consistent ... dosing and one to three hours post-dosing on day 28. The relationship between PK and all bleeding ...

DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD

... endpoint is the treatment failure rate at Study day 80. This endpoint was successfully measured as a ... endpoint of the 'treatment failure rate at Study day 80,' we expect to replicate statistical ... namely median time-to-treatment failure through day 50 (p-value 0.1177), orBec(R) did achieve ...

ISTA Pharmaceuticals Announces Positive Results for Phase 2 Study of Low-Dose Bromfenac in Dry Eye Disease

... received low-dose bromfenac bilaterally twice a day for 42 days. Patient baseline scores were ... bromfenac and were compared to baseline at day 14, day 42 ...

Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry

... - Improvement Was Noted At day 3 And All Subsequent Study Visits - FORT ... assessments at all study visits starting at day 3. In addition, lurasidone was generally ... arms. Patients remained in the hospital until the day 28 assessment after which patients could be ...

ADVENTRX Announces Results From ANX-514 Bioequivalence Study

... dose of ANX-514 was a secondary objective. On day 1, patients were dosed with either ANX-514 or Taxotere and, on day 22, were dosed with the other drug. Patients ... with corticosteroids prior to treatment on day 1 and ...

ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients

... log10 reduction in viral load). Viral load at day 4 (12 hours after the last dose) was compared to ... and the engagement of clinical sites. 14 day Healthy Volunteer Study Anadys recently ... mg bid). Subjects received ANA598 or placebo on day one followed by pharmacokinetic assessment over ...

Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer

... PI plasma concentration levels. After a 7 day washout period, subjects were randomized to 15 ... mg, 50 mg, or 200 mg) once daily or placebo. On day 15, subjects also received, once again, either ... with the final dose of SPI-452. On day 16 subjects received darunavir, atazanavir or ...

ISTA Pharmaceuticals Announces Positive Results for Phase IIb Study of Ecabet Sodium

... either ecabet sodium or placebo four times per day for 43 days. The object of the study was to ... Schirmer Test score was seen as early as day 22 of treatment and continued to trend upwards through day 43. Adverse events were uncommon and similar ...

Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer

... mg/m2 followed by docetaxel 60 mg/m2 on the first day of every 21-day cycle; or docetaxel 75 mg/m2 on the first day of every 21-day cycle. Treatment continued until ... reactions have resolved within several hours to a day once the infusion is terminated. In some ...

Pharmasset Reports Fiscal Year End 2008 Financial Results

... covering R7128. Results from the 28 day study were presented at the recent ... 2009 -- Report end of treatment data from 28 day add-on study with R7128 in non-responder, ... -- Report end of treatment results from 28 day add-on study with R7128 in treatment ...

Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin

... dosed intravenously at 300 mg and 450 mg twice a day to patients with cSSSI for 5 to 14 days, as ... of chronic bronchitis (ABECB). A 200 mg once a day dose of delafloxacin for 5 days was shown to be as efficacious as a 500 mg once a day dose for 7 days of levofloxacin. About ...

Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer

... placebo group. Treatment was started on the first day of the current cycle of chemotherapy and was ... infusion, just after the infusion, and then every day for five days to ensure that the reversibility ... pulmonary embolism, and all-cause mortality up to day 17. The main safety endpoint was major bleeding ...

Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes

... (75 mg/m^2), and TBI (1320 cGy), followed one day later by an infusion of one unit of non-cultured ... early engraftment, the engrafted cells present at day seven were derived almost entirely from the ... at 180 days post-transplant. One patient died on day 462 from a rare complication of myelitis ...

ISTA Pharmaceuticals Announces Phase III Results for Once-Daily Topical Xibrom(TM) 0.09%

... endpoint of elimination of ocular pain one day post surgery. When considered ... Xibrom once daily or placebo. Dosing began one day before cataract surgery and continued for 14 days ... of patients experiencing no pain was assessed at day 1 post surgery, and the proportion of patients ...

Micromet Expands Committed Equity Financing Facility to $75 Million

... closing price of the common stock on the trading day prior to the draw down notice, in each case ... provided that if the average market price on any day during the pricing period is less than the greater of $2.00 or 85% of the closing price of the day preceding the ...

Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts

... & Gender Equity: WHAT: World AIDS day Audio Media Conference WHEN: ... are calling on the United States this World AIDS day to prioritize effective prevention alongside ... faiths and beliefs will gather for a World AIDS day Interfaith Service in Washington, D.C. This ...

Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented

... as effective as Pred Forte dosed eight times a day in treating uveitis. Durezol was also safe and ... equal to 1 cell) than did the Pred Forte group at day 14 (69% vs. 62%, respectively). This trend continued through day 42. Pain/ocular discomfort was assessed using a ...

Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008

... discontinuations during this 28 day treatment period. The most common adverse ... Mean reductions of HCV RNA from baseline to day seven with TMC435 alone and in triple therapy ... achieved undetectable HCV RNA (<10 IU/mL) at day 28 (RVR=89 percent). "These data provide ...

Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting

... with radezolid at a dosage of 450 mg once a day (38/39); 94.4% for patients treated with radezolid 450 mg twice a day (36/39); and 97.4% for patients treated with linezolid 600 mg twice a day (37/38). Clinical cure rates among clinically ...

Minster Pharmaceuticals Plc Announces Positive Results from Phase II Trial of Migraine with Aura

... patients took either tonabersat or placebo once a day for a three-month period after which the ... and vice versa. The tonabersat dosage was 20mg a day for the first two weeks, increasing to 40mg a day for the subsequent 10 weeks. In line with ...

Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)

... steroid that can be used effectively four times a day to reduce inflammation in patients with moderate ... equal to 1 cell) than did the Pred Forte group at day 14 (69% vs 62%, respectively). This trend continued through day 42. Ocular discomfort and pain is a ...

Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain

... inflammation in which treatment was initiated one day prior to surgery. The multicenter, randomized, ... and relieving ocular pain/discomfort as early as day 3/4." A significantly greater percentage of ... to 5 anterior chamber cells and no flare) by day 14: 81.3% of the Durezol treated patients in the ...

Transdel Enrolls First Patient for Ketotransdel(TM) Phase 3 Clinical Trial

... pain between Ketotransdel(TM) and placebo at day 3. This endpoint is measured by using the Visual ... and other efficacy parameters measured by VAS at day 3 and day 7. In addition to evaluating for efficacy and ...

Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis

... twice and Enbrel was administered either every day for the first 14 days (for the histopathology and immunology studies) or every other day over the entire study period of 28 days (for the ... Dr. Zimmerman. "I hope that CEL-2000 will some day be used to lessen the damage caused by rheumatoid ...

Soyfoods Do Not Impact Sperm Count

... soyfoods as less than 3 ounces of a beverage per day -- about one 8 ounce glass of a beverage every ... sperm/cc seminal fluid) is highly variable from day to day and seasonally in all men. This is most clear ...

New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer

... results suggest that four to five cups of tea a day may improve attention and focus. This and other ... equal to about two to four cups of green tea per day was provided to animals with induced Parkinsonism ... that drinking three or more cups of tea per day delayed motor symptoms by 7.7 years. In addition ...

Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data

... four-fold increase from baseline HI titers. By day 56, at least 50% and up to 67% of evaluable ... HI titers of 40 or more in 44% of subjects by day 56. Even at the lowest dose tested (0.033 mg H5 DNA), one of the six subjects was a responder by day 56. Some subjects who received the highest H5 DNA ...

U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease

... with Parkinson's disease by 2.1 hours per day on average, compared to baseline. Specifically, ... reduced "off" time by an average of 2.1 hours per day from baseline, compared to a reduction of 0.4 hours per day for placebo. Once-daily use of Requip XL was ...

Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections

... at 28 days after completion of dosing, which was day 56 of the study. Pulmonary function (FEV1) ... (p=0.009) increase compared to placebo, at day 56. Arikace was well tolerated, with no ... infection. The ability to deliver a drug once a day that may penetrate the CF biofilm and achieve a ...

Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients

... side effects. Importantly, the 30 day all-cause mortality, one of the secondary ... clofarabine administered as 30mg/m2 per day for five consecutive days then, based on their ... cycles of treatment at a dose of 20 mg/m2 per day for five consecutive days. Significant Unmet ...

Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma

... mg/m2 on days 1, 4, 8, 11, DOXIL at 30 mg/m2 on day 4 and dexamethasone at 40 mg on days 1 through 4, ... 1 through 21 plus prednisone at 50 mg every other day for four, 28-day LP cycles. This was followed by ... dexamethasone at 40 or 20 mg on the day of and day after each VELCADE dose. Patients were treated ...

GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)

... IV/oral dose regimen (90mg IV and OND on day one and 50mg tablets on days two and three) ... oral casopitant doses (a single 150mg tablet on day one, or a 150mg tablet on day one followed by 50mg on days two and three) and ...

International Symposium on Malignant Mesothelioma 2008

... and terminal effects of this tragic cancer. day 1: Advocacy, Thursday, June 26 is a rallying cry ... impressive and prestigious group of panelists for day 2: Science, Friday, June 27. A Gala Dinner will ... a personal perspective as a featured speaker. day 3: Community, Saturday, June 28, will be devoted ...

Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference

... and placebo groups and challenged three times a day with gluten or gluten placebo during a 14 day period. Four doses of the oral formulation of ... the prevention of increase in LAMA ratio from day 0 ...

Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients

... design study. COPD patients entered a 7-14 day run-in period during which subjects received ... following the first dose of study medication at day 1 was statistically significantly improved in the ... (SGRQ), the results of which were similar at day 1 and did not change markedly over the six weeks ...

Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW

... the first dose of study medication and the first day of symptom resolution (rectal bleeding ... the first dose of study medication and the first day of three consecutive days of symptom resolution. ... resolution of rectal bleeding at the first day and first of three days, respectively: ...

Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being

... 0.015 mg of ethinyl estradiol (an estrogen), per day over a twenty-one day period of use. NUVARING has an outer diameter ... the ring is removed three weeks later on the same day of the week as it was inserted and at about the ...

Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment

... by a single retrospective "recall" report at day 28, was not met. However, an assessment of ... scale (VAS) measurements 12 hours after dosing at day 7 and day 28 revealed significant improvement in the ...

Family of Three Americans Become Pain Free and Improve Their Quality of Life With Stem Cell Treatment in Mexico

... their quality of life." At the end of the first day of treatment, the Aguilar's were starting to ... close to being pain free just after the first day of treatment. The following morning ... regenerative process. After the third and final day of their treatment the Aguilars' were true ...
Other Contentsendosymbiosisendosymbiosisendothermentropyentropyenvironmentenvironmentenvironmentenvironmentenvironmentenvironmentenvironmentenvironmentenvironmentdamagedamagedamagedamagedamagedamagedamagedamagedamagedamageenvironmentalenvironmentalenvironmentalenvironmentalenvironmentalenvironmentalenvironmentalenvironmentaleosinophilseosinophils
(Date:12/4/2009)...skovar, a Texas AgriLife Research plant physiologi...nter in Uvalde, has been investigating ways to hel...n from the greenhouse to the field. , "This rese...ibly even the further profitability of some vegeta... plants that will establish well," Leskovar said. ...
(Date:12/4/2009)...lable in German . , A new study of the Max Pl... understand the positive effect of dietary restric...ferent organisms (fruit flies and mice) have shown... with a potential negative side effect of diminish...ess frequently with a reduced litter size on a low...
(Date:12/3/2009)...n new information and adapt to changes in our dail...ies, appears to lie in the minute junctions where ...by NYU Langone Medicine Center researchers. The st...Nature . , The scientists, led by Wen-Biao Gan,...cience at NYU School of Medicine, discovered that ...
Breaking Biology News(10 mins):Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4How nutrition affects healthy aging 2Lifelong memories linked to stable nerve connections 2NIDDK announces availability of more current kidney disease data 58802 1NIDDK announces availability of more current kidney disease data 58802 2The real world of a forensic scientist 10247 1The real world of a forensic scientist 10247 2Uncertainty Surrounds Testing for Alzheimers 58797 1Uncertainty Surrounds Testing for Alzheimers 58797 2Uncertainty Surrounds Testing for Alzheimers 58797 3
(Date:12/4/2009)...w study shows that muscle cells grown in the lab c...properly. The work, performed in dogs and rats, mi... such as gastric reflux and fecal incontinence. ,...ers, which are the bands of muscle that separate t...ss in these areas can cause gastrointestinal esoph...
(Date:12/4/2009)...t men can be bastards and women must wear pearls a...nswer, according to an article in the Journal of ...xpressions. , In two studies, researchers asked ... In the first study, androgynous faces with lowere... more likely to be identified as male, and faces w...
(Date:12/4/2009)... federal regulators to crack down on abuse of opio...hDay News) -- The makers of 24 different prescript...tors with plans to curb the abuse of these opioid ...n under pressure from U.S. Food and Drug Administr... of fatal overdoses that occur with these medicati...
(Date:12/4/2009)... back during winter isn,t known, CDC says, , ...ber of states reporting widespread swine flu activ... high of 48 just two weeks ago, a U.S. health offi...N1 swine flu vaccine continues to increase, Dr. Th...Disease Control and Prevention, said during an aft...
(Date:12/4/2009)...lood vessel growth after heart attack , ,...lls appear to help repair heart attack damage, a n...nts found that stem cells from donor bone marrow p...issue damaged by heart attack. , The patients r... having a heart attack. During follow-up, they wer...
Breaking Medicine News(10 mins):Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Are angry women more like men? 2Health News:Makers of Powerful Painkillers Present Safety Plans 2Health News:Swine Flu Continues to Wane 2
Other TagsCouchConnectionConnectionGraphicGraphicGraphicInsightsInsightsDangerDangerCaregiverOther Tagscontinual 2turned 2turned 3turned 4turned 5turned 6turned 7turned 8turned 9turned 10leading 2leading 3leading 4leading 5leading 6leading 7leading 8leading 9leading 10resist 2resist 3age 2age 3age 4age 5age 6age 7age 8age 9age 10years 2years 3years 4years 5years 6years 7years 8years 9years 10add 2add 3add 4add 5add 6add 7add 8add 9text 2